Detalhe da pesquisa
1.
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Am J Gastroenterol
; 118(7): 1237-1247, 2023 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36716287
2.
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study.
Gastroenterol Hepatol
; 45(3): 165-176, 2022 Mar.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-34051313
3.
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
Dig Dis Sci
; 64(3): 846-854, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30426297
4.
Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.
Scand J Gastroenterol
; 53(2): 152-157, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29189092
5.
Relative adrenal insufficiency in severe acute variceal and non-variceal bleeding: influence on outcomes.
Liver Int
; 35(8): 1964-73, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25644679
6.
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.
J Crohns Colitis
; 18(1): 65-74, 2024 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37522878
7.
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.
Pharmaceutics
; 16(5)2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38794292
8.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Therap Adv Gastroenterol
; 17: 17562848231221713, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38187926
9.
Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial.
Trials
; 24(1): 432, 2023 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37365665
10.
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.
J Clin Med
; 11(2)2022 Jan 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35054116
11.
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).
J Clin Med
; 11(24)2022 Dec 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36556155
12.
Noninvasive assessment of liver fibrosis in Crohn's disease patients exposed to methotrexate.
Eur J Gastroenterol Hepatol
; 33(6): 794-798, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32804842
13.
Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.
J Crohns Colitis
; 15(1): 35-42, 2021 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32969471
14.
[Usefulness of octreotride in preventing non-variceal gastroinetestinal bleeding in liver cirrhosis: A report of two cases]. / Utilidad del octreotide en la prevención de la hemorragia digestiva no variceal en cirrosis hepática: descripción de 2 casos.
Gastroenterol Hepatol
; 38(6): 386-7, 2015.
Artigo
Espanhol
| MEDLINE | ID: mdl-25728741
15.
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
United European Gastroenterol J
; 8(9): 1056-1066, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32723069
16.
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflamm Bowel Dis
; 26(4): 606-616, 2020 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31504569
17.
Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis.
J Crohns Colitis
; 13(3): 385-388, 2019 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-30346606
18.
Prevalence and risk factors for colorectal adenomas in patients with ulcerative colitis.
United European Gastroenterol J
; 6(2): 322-330, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29511562
19.
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Aliment Pharmacol Ther
; 48(8): 839-851, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30281832
20.
Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study / Rapidez de la respuesta clínica a adalimumab y mejora de la calidad de vida en la enfermedad de Crohn luminal: estudio RAPIDA
Gastroenterol. hepatol. (Ed. impr.)
; 45(3): 165-176, Mar. 2022. tab, graf
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-204204